1. Home
  2. VALN vs ECVT Comparison

VALN vs ECVT Comparison

Compare VALN & ECVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • ECVT
  • Stock Information
  • Founded
  • VALN 2012
  • ECVT 1935
  • Country
  • VALN France
  • ECVT United States
  • Employees
  • VALN N/A
  • ECVT N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • ECVT Major Chemicals
  • Sector
  • VALN Health Care
  • ECVT Industrials
  • Exchange
  • VALN Nasdaq
  • ECVT Nasdaq
  • Market Cap
  • VALN 777.9M
  • ECVT 926.8M
  • IPO Year
  • VALN 2021
  • ECVT 2017
  • Fundamental
  • Price
  • VALN $10.44
  • ECVT $8.39
  • Analyst Decision
  • VALN Strong Buy
  • ECVT Buy
  • Analyst Count
  • VALN 4
  • ECVT 3
  • Target Price
  • VALN $15.75
  • ECVT $12.17
  • AVG Volume (30 Days)
  • VALN 77.5K
  • ECVT 1.5M
  • Earning Date
  • VALN 11-06-2025
  • ECVT 10-30-2025
  • Dividend Yield
  • VALN N/A
  • ECVT N/A
  • EPS Growth
  • VALN N/A
  • ECVT N/A
  • EPS
  • VALN N/A
  • ECVT N/A
  • Revenue
  • VALN $230,566,060.00
  • ECVT $723,462,000.00
  • Revenue This Year
  • VALN $15.69
  • ECVT $14.65
  • Revenue Next Year
  • VALN $22.15
  • ECVT $0.39
  • P/E Ratio
  • VALN N/A
  • ECVT N/A
  • Revenue Growth
  • VALN 25.47
  • ECVT 4.93
  • 52 Week Low
  • VALN $3.62
  • ECVT $5.24
  • 52 Week High
  • VALN $12.25
  • ECVT $9.69
  • Technical
  • Relative Strength Index (RSI)
  • VALN 51.09
  • ECVT 43.25
  • Support Level
  • VALN $10.08
  • ECVT $8.15
  • Resistance Level
  • VALN $11.35
  • ECVT $8.44
  • Average True Range (ATR)
  • VALN 0.43
  • ECVT 0.24
  • MACD
  • VALN -0.13
  • ECVT -0.04
  • Stochastic Oscillator
  • VALN 29.25
  • ECVT 41.12

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About ECVT Ecovyst Inc.

Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has two reporting segments: Ecoservices and Advanced Materials & Catalysts. Ecoservices provides sulfuric acid recycling to the North American refining industry for the production of alkylate and provides on-purpose virgin sulfuric acid for water treatment, mining, and industrial applications. Maximum revenue is generated from Ecoservices segment.

Share on Social Networks: